Pemetrexed Disodium was first introduced by Eli Lilly And Co in its drug Alimta on Feb 4, 2004. Other drugs containing Pemetrexed Disodium are Pemetrexed Disodium, Pemetrexed. 21 different companies have introduced drugs containing Pemetrexed Disodium.

Pemetrexed Disodium Patents

Given below is the list of patents protecting Pemetrexed Disodium, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Pemetrexed	US11147817	Pharmaceutical composition of pemetrexed	Mar 26, 2035	Shilpa
Alimta	US7772209 (Pediatric)	Antifolate combination therapies	May 24, 2022 (Expired)	Lilly
Alimta	US7772209	Antifolate combination therapies	Nov 24, 2021 (Expired)	Lilly
Alimta	US5344932 (Pediatric)	N-(pyrrolo(2,3-d)pyrimidin-3-ylacyl)-glutamic acid derivatives	Jan 24, 2017 (Expired)	Lilly
Alimta	US5344932	N-(pyrrolo(2,3-d)pyrimidin-3-ylacyl)-glutamic acid derivatives	Jul 24, 2016 (Expired)	Lilly

Add above patents to watchlist

Pemetrexed Disodium's Family Patents

Full family tree

Pemetrexed Disodium Generic API Manufacturers

Several generic applications have been filed for Pemetrexed Disodium. The first generic version for Pemetrexed Disodium was by Fresenius Kabi Usa Llc and was approved on May 25, 2022. And the latest generic version is by Hetero Labs Ltd Unit Vi and was approved on Jun 14, 2024.

Given below is the list of companies who have filed for Pemetrexed Disodium generic, along with the locations of their manufacturing plants worldwide.